« Return to News | Technology Solutions

Forte launches Overture electronic data capture system

Friday, July 12, 2013 03:14 PM

Forte Research Systems, a developer of clinical research management software, has launched its electronic data capture (EDC) system. Overture EDC is for researchers in the academic setting that need a system to handle complex clinical research protocols.

“We knew that many researchers were making the move from paper to EDC, but were having challenges finding systems with the right features at the right price,” said Srini Kalluri, founder, president, chief executive officer and chief customer officer at Forte Research Systems. 

Forte has over a dozen years of experience developing software for clinical research sites that have collectively used these systems to manage over 20,000 clinical trials, and has designed an EDC system that draws on the insights of its customer community. Features include hosted software available to license on a per-trial basis and drag-and-drop functionality.

“With Overture EDC, research staff can set up electronic case report forms in a matter of hours, without needing to know any programming language. This puts the focus back on the trial instead of on the technology to support it,” said Kalluri.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.